Apellis Pharmaceuticals (APLS) PT Raised to $22 at Scotiabank
Tweet Send to a Friend
(Updated - July 30, 2025 8:34 AM EDT)
Scotiabank analyst Greg Harrison raised the price target on Apellis Pharmaceuticals ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Scotiabank analyst Greg Harrison raised the price target on Apellis Pharmaceuticals ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
